Medicine and Dentistry
Thalidomide
100%
Dexamethasone
75%
T-Helper Cell
66%
Therapeutic Procedure
41%
T Cell Subset
33%
T Cell Proliferation
33%
Co-Stimulatory Molecule
33%
Cells
33%
Cell Population
16%
Glucocorticoid Induced Tumor Necrosis Factor Receptor
16%
Anti-Inflammatory Drug
16%
T Cell
16%
Serositis
8%
Cytokine
8%
Flow Cytometry
8%
Combination Therapy
8%
Malignant Neoplasm
8%
Incubation
8%
Drug Therapy
8%
Chemotherapeutic Agent
8%
Drug
8%
Multiple Myeloma
8%
Lupus Nephritis
8%
Immunology and Microbiology
Thalidomide
100%
Dexamethasone
75%
Regulatory T Cell
33%
Cells
33%
Cell Population
16%
Immunity
16%
C57BL 6 Mouse
8%
Glucocorticoid
8%
Tumor Necrosis Factor Receptor
8%
Naive T Cell
8%
Nephritis
8%
Multiple Myeloma
8%
Mouse
8%
Inflammation
8%
Dose
8%
Lupus Erythematosus
8%
Pharmacology, Toxicology and Pharmaceutical Science
Thalidomide
100%
Dexamethasone
75%
Glucocorticoid Induced Tumor Necrosis Factor Receptor
16%
Cytokine
8%
C57BL 6 Mouse
8%
Drug
8%
Multiple Myeloma
8%
Malignant Neoplasm
8%
Lupus Erythematosus Nephritis
8%
Mouse
8%
Biochemistry, Genetics and Molecular Biology
Dexamethasone
75%
T Cell
16%
Cytokine
16%
Flow Cytometry
8%
C57BL 6 Mouse
8%
Tumor Necrosis Factor Receptor
8%
Glucocorticoid
8%
Mouse
8%
Protein
8%
Dose
8%
Naive T Cell
8%